These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 11696618

  • 1. Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of Japan Clinical Oncology Group Study (JCOG 9601).
    Tsuchiya S, Ohe Y, Sugiura T, Fuwa N, Kitamoto Y, Mori K, Kobayashi H, Nakata K, Sawa T, Hirai K, Etoh T, Saka H, Saito A, Fukuda H, Ishizuka N, Saijo N, Japan Clinical Oncology Group Study.
    Jpn J Clin Oncol; 2001 Oct; 31(10):488-94. PubMed ID: 11696618
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y, Ueoka H, Kiura K, Kamei H, Tabata M, Sakae K, Hiraki Y, Kawahara S, Eguchi K, Hiraki S, Harada M.
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [Abstract] [Full Text] [Related]

  • 7. Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04.
    Komaki R, Seiferheld W, Ettinger D, Lee JS, Movsas B, Sause W.
    Int J Radiat Oncol Biol Phys; 2002 Jul 01; 53(3):548-57. PubMed ID: 12062596
    [Abstract] [Full Text] [Related]

  • 8. Alternating radiotherapy and chemotherapy for inoperable Stage III non-small-cell lung cancer: long-term results of two Phase II GOTHA trials. Groupe d'Oncologie Thoracique Alpine.
    Mirimanoff RO, Moro D, Bolla M, Michel G, Brambilla C, Mermillod B, Miralbell R, Alberto P.
    Int J Radiat Oncol Biol Phys; 1998 Oct 01; 42(3):487-94. PubMed ID: 9806505
    [Abstract] [Full Text] [Related]

  • 9. Rapidly alternating combination of cisplatin-based chemotherapy and hyperfractionated accelerated radiotherapy in split course for stage IIIA and stage IIIB non-small cell lung cancer: results of a phase I-II study by the GOTHA group. Group d'Oncologie Thoracique des Régions Alpines.
    Alberto P, Mirimanoff RO, Mermillod B, Leyvraz S, Nagy-Mignotte H, Bolla M, Wellmann D, Moro D, Brambilla E.
    Eur J Cancer; 1995 Oct 01; 31A(3):342-8. PubMed ID: 7786599
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: long-term follow-up results. Japan Clinical Oncology Group Protocol 8902.
    Kubota K, Tamura T, Fukuoka M, Furuse K, Ikegami H, Ariyoshi Y, Kurita Y, Saijo N.
    Ann Oncol; 2000 Apr 01; 11(4):445-50. PubMed ID: 10847464
    [Abstract] [Full Text] [Related]

  • 12. Sequential treatment with vindesine-ifosfamide-platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: a phase II trial.
    Van den Brande P, De Ruysscher D, Vansteenkiste J, Spaas P, Specenier P, Demedts M.
    Lung Cancer; 1998 Oct 01; 22(1):45-53. PubMed ID: 9869107
    [Abstract] [Full Text] [Related]

  • 13. Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trial.
    Pöttgen C, Eberhardt WE, Gauler T, Krbek T, Berkovic K, Jawad JA, Korfee S, Teschler H, Stamatis G, Stuschke M.
    Int J Radiat Oncol Biol Phys; 2010 Mar 01; 76(3):809-15. PubMed ID: 19427744
    [Abstract] [Full Text] [Related]

  • 14. A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer.
    Atagi S, Kawahara M, Hosoe S, Ogawara M, Kawaguchi T, Okishio K, Naka N, Sunami T, Mitsuoka S, Akira M.
    Lung Cancer; 2002 Apr 01; 36(1):105-11. PubMed ID: 11891041
    [Abstract] [Full Text] [Related]

  • 15. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
    Furuse K, Fukuoka M, Kawahara M, Nishikawa H, Takada Y, Kudoh S, Katagami N, Ariyoshi Y.
    J Clin Oncol; 1999 Sep 01; 17(9):2692-9. PubMed ID: 10561343
    [Abstract] [Full Text] [Related]

  • 16. Concurrent cisplatin-vindesine and hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer.
    Le Péchoux C, Arriagada R, Le Chevalier T, Bretel JJ, Cosset BP, Ruffié P, Baldeyrou P, Grunenwald D.
    Int J Radiat Oncol Biol Phys; 1996 Jun 01; 35(3):519-25. PubMed ID: 8655375
    [Abstract] [Full Text] [Related]

  • 17. Mitomycin, cisplatin, and vindesine followed by radiotherapy combined with cisplatin in stage III nonsmall cell lung cancer: long-term results.
    Tejedor M, Valerdi JJ, López R, Domínguez MA, Arias F, Illarramendi JJ, Martínez E.
    Int J Radiat Oncol Biol Phys; 1995 Feb 15; 31(4):813-8. PubMed ID: 7860393
    [Abstract] [Full Text] [Related]

  • 18. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group.
    Sause W, Kolesar P, Taylor S IV, Johnson D, Livingston R, Komaki R, Emami B, Curran W, Byhardt R, Dar AR, Turrisi A.
    Chest; 2000 Feb 15; 117(2):358-64. PubMed ID: 10669675
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Concurrent high-dose thoracic irradiation plus daily low-dose cisplatin and vindesine in locally advanced unresectable stage III non-small cell lung cancer].
    Nakano K, Kumagai K, Ishida H, Kohjima N, Hiramoto T, Hada Y.
    Gan To Kagaku Ryoho; 1996 Jan 15; 23(1):57-61. PubMed ID: 8546470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.